Human RecQL4 as a Novel Molecular Target for Cancer Therapy

Area of Science:

• Genetics
• Molecular Biology
• Oncology

Background:

• Human RecQ helicases are vital for maintaining genomic stability.
• Mutations in three RecQ helicases cause rare genetic disorders like Werner syndrome, Bloom syndrome, and Rothmund-Thomson syndrome.
• RecQL4 mutations are linked to Rothmund-Thomson syndrome type II, RAPADILINO, and Baller-Gerold syndrome.

Purpose of the Study:

• To review the role of RecQL4 in genomic stability and its connection to cancer.
• To explore the potential of RecQL4 as a novel therapeutic target for cancer treatment.

Main Methods:

• Literature review of studies on RecQ helicases, focusing on RecQL4.
• Analysis of the relationship between RecQL4 mutations/expression and cancer susceptibility.
• Discussion of current and future therapeutic strategies targeting RecQL4.

Main Results:

• RecQL4 plays a critical role in DNA metabolic activities essential for genomic stability.
• Increased osteosarcoma incidence in RecQL4-mutated patients and elevated RecQL4 expression in sporadic cancers indicate its link to cancer susceptibility.
• Dysregulation of RecQL4 expression (loss or gain) is associated with increased cancer risk.

Conclusions:

• RecQL4 is a key player in maintaining genomic integrity.
• Altered RecQL4 expression is implicated in cancer development, particularly osteosarcoma.
• RecQL4 presents a promising target for future cancer therapies.